Clinical Trial

MRI in Transcatheter Aortic Valve Replacement Patients

Study acronym: MRI-TAVR
Recruiting
View on ClinicalTrials.gov →
Summary
The hypothesis is that SEV result in superior valvular hemodynamics (more pronounced during exercise) and exercise capacity relative to BEV. Furthermore, the hypothesis is that stress CMR will be able to demonstrate differences in these hemodynamic parameters. CMR will also provide refined assessment of paravalvular leak and its impact on ventricular function and on clinical outcomes.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2022-11-01; most recent amendment 2025-12-14.
Status change: Not Yet Recruiting → Recruiting 2023-11-28
Trial Details
NCT Number NCT05603026
Lead Sponsor University Hospitals Cleveland Medical Center
Conditions Aortic Valve Stenosis
Enrollment 90 participants
Start Date 2023-11-21
Primary Completion 2026-12-30 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-12-17